Hiroaki Hagihara

608 total citations
25 papers, 427 citations indexed

About

Hiroaki Hagihara is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, Hiroaki Hagihara has authored 25 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hepatology, 10 papers in Epidemiology and 7 papers in Oncology. Recurrent topics in Hiroaki Hagihara's work include Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Liver Disease Diagnosis and Treatment (8 papers) and Cancer, Lipids, and Metabolism (6 papers). Hiroaki Hagihara is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Liver Disease Diagnosis and Treatment (8 papers) and Cancer, Lipids, and Metabolism (6 papers). Hiroaki Hagihara collaborates with scholars based in Japan, United States and Greece. Hiroaki Hagihara's co-authors include Kazuhiro Nouso, Kenji Kuwaki, Kazuhide Yamamoto, Shinichiro Nakamura, Hidenori Shiraha, Akinobu Takaki, Fusao Ikeda, Junichi Toshimori, Yasuhiro Miyake and Hideki Onishi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Cancer.

In The Last Decade

Hiroaki Hagihara

23 papers receiving 421 citations

Peers

Hiroaki Hagihara

HEPAT

EPIDE

ONCOL

Dawn Q. Chong Singapore

Moon Soo Koh South Korea

Kevin Perraud Switzerland

Massimo De Giorgio Italy

Zhang Cheng China

Sayo Kobayashi Japan

Erlei Zhang China

Hesham M. Hassabo United States

Toshimi Nakanishi Japan

Luca Ielasi Italy

Dawn Q. Chong Singapore

Hiroaki Hagihara

116 ×0.5

HEPAT

191 ×1.2

EPIDE

141 ×1.0

149 ×1.6

115 ×1.6

ONCOL

Citations per year, relative to Hiroaki Hagihara Hiroaki Hagihara (= 1×) peers Dawn Q. Chong

Countries citing papers authored by Hiroaki Hagihara

Since Specialization

Citations

This map shows the geographic impact of Hiroaki Hagihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Hagihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Hagihara more than expected).

Fields of papers citing papers by Hiroaki Hagihara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Hagihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Hagihara. The network helps show where Hiroaki Hagihara may publish in the future.

Co-authorship network of co-authors of Hiroaki Hagihara

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Hagihara. A scholar is included among the top collaborators of Hiroaki Hagihara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Hagihara. Hiroaki Hagihara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Matsumoto, Kazuyuki, Akinobu Takaki, Takuya Adachi, et al.. (2024). Anti-PD-1 Autoantibody Predicts Survival of Patients With Hepatocellular Carcinoma Receiving Atezolizumab/Bevacizumab. SHILAP Revista de lepidopterología. 3(8). 1138–1147.

Takeuchi, Yasuto, Kazuhiro Nouso, Shinichi Fujioka, et al.. (2023). The prediction of early progressive disease in patients with hepatocellular carcinoma receiving atezolizumab plus bevacizumab. Cancer Medicine. 12(17). 17559–17568. 3 indexed citations

Nakamura, Shinichiro, Kazuhiro Nouso, Hiroyuki Okada, et al.. (2019). Hepatocellular carcinoma recurrence in HCV patients treated with direct-acting antivirals after curative treatment. Hepatoma Research. 2019. 2 indexed citations

Nakamura, Shinichiro, Kazuhiro Nouso, Hideki Onishi, et al.. (2014). Prevention of vagotonia and pain during radiofrequency ablation of liver tumors. Hepatology Research. 44(13). 1367–1370. 6 indexed citations

Tomoda, Takeshi, Kazuhiro Nouso, Koji Miyahara, et al.. (2013). Prognotic impact of serum follistatin in patients with hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 28(8). 1391–1396. 20 indexed citations

Miyahara, Koji, Kazuhiro Nouso, Yuki Morimoto, et al.. (2013). Efficacy of sorafenib beyond first progression in patients with metastatic hepatocellular carcinoma. Hepatology Research. 44(3). 296–301. 20 indexed citations

Kobayashi, Sayo, Kazuhiro Nouso, Hideaki Kinugasa, et al.. (2012). Clinical utility of serum fucosylated hemopexin in Japanese patients with hepatocellular carcinoma. Hepatology Research. 42(12). 1187–1195. 18 indexed citations

Takeuchi, Yasuto, Fusao Ikeda, Hiroaki Hagihara, et al.. (2012). The impact of patatin-like phospholipase domain-containing protein 3 polymorphism on hepatocellular carcinoma prognosis. Journal of Gastroenterology. 48(3). 405–412. 30 indexed citations

Horiguchi, Shigeru, Fusao Ikeda, Hidenori Shiraha, et al.. (2012). Diagnostic usefulness of precise examinations with intraductal ultrasonography, peroral cholangioscopy and laparoscopy of immunoglobulin G4‐related sclerosing cholangitis. Digestive Endoscopy. 24(5). 370–373. 9 indexed citations

10.

Shiraha, Hidenori, Yutaka Nakanishi, Shinichi Nishina, et al.. (2012). Runt‐related transcription factor 3 reverses epithelial–mesenchymal transition in hepatocellular carcinoma. International Journal of Cancer. 131(11). 2537–2546. 47 indexed citations

11.

Nishimura, Mamoru, Akinobu Takaki, Naofumi Tamaki, et al.. (2012). Serum oxidative–anti‐oxidative stress balance is dysregulated in patients with hepatitis C virus‐related hepatocellular carcinoma. Hepatology Research. 43(10). 1078–1092. 13 indexed citations

12.

Miyahara, Koji, Kazuhiro Nouso, Yuki Morimoto, et al.. (2012). Evaluation of the effect of sorafenib using serum NX‐des‐γ‐carboxyprothrombin in patients with hepatocellular carcinoma. Hepatology Research. 43(10). 1064–1070. 15 indexed citations

13.

Nakanishi, Yutaka, Hidenori Shiraha, Minoru Matsubara, et al.. (2011). Loss of runt-related transcription factor 3 expression leads hepatocellular carcinoma cells to escape apoptosis. BMC Cancer. 11(1). 3–3. 26 indexed citations

14.

Kinugasa, Hideaki, Kazuhiro Nouso, Yasuto Takeuchi, et al.. (2011). Risk factors for recurrence after transarterial chemoembolization for early-stage hepatocellular carcinoma. Journal of Gastroenterology. 47(4). 421–426. 32 indexed citations

15.

Miyahara, Koji, Kazuhiro Nouso, Takeshi Tomoda, et al.. (2011). Predicting the treatment effect of sorafenib using serum angiogenesis markers in patients with hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 26(11). 1604–1611. 69 indexed citations

16.

Kinugasa, Hideaki, Kazuhiro Nouso, Yoshiyuki Kobayashi, et al.. (2011). Hepatocellular carcinoma occurring in hepatobiliary fibropolycystic disease. Hepatology Research. 41(3). 277–281. 1 indexed citations

17.

Kobayashi, Yoshiyuki, Yoshiaki Iwasaki, Shinichiro Nakamura, et al.. (2011). Effect of Previous Interferon Treatment on Outcome After Curative Treatment for Hepatitis C Virus-Related Hepatocellular Carcinoma. Digestive Diseases and Sciences. 57(4). 1092–1101. 21 indexed citations

18.

Nouso, Kazuhiro, Yoshiyuki Kobayashi, Shinichiro Nakamura, et al.. (2011). Prognostic importance of fucosylated alpha‐fetoprotein in hepatocellular carcinoma patients with low alpha‐fetoprotein. Journal of Gastroenterology and Hepatology. 26(7). 1195–1200. 33 indexed citations

19.

Hagihara, Hiroaki, Kazuhiro Nouso, Yoshiyuki Kobayashi, et al.. (2010). Effect of pegylated interferon therapy on intrahepatic recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma. International Journal of Clinical Oncology. 16(3). 210–220. 39 indexed citations

20.

Kosaka, Takeo, Shigeru Takegawa, Masashi Kato, et al.. (1992). A Long Surviving Case of Remnant Stomach Cancer with Paraaortic Lymph-node Metastasis. A Patient with Three Primary Cancers Including Remnant Stomach Cancer Gallbladder Cancer and Breast Cancer.. The Japanese Journal of Gastroenterological Surgery. 25(8). 2176–2180.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact